Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
The 2024 Analytical & Life Science Instrumentation Service Market
... Whether provided by the original instrument manufacturer or by a third party service provider, the service market includes all service contracts and any replacement parts installed during servicing. Other services like software support and validation ... Read More
-
2024 Italy Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
... evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors ... Read More
-
Biofuel Enzymes
... at a CAGR of 8.3% over the analysis period 2023-2030. Amylase, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$683.8 Million by the end of the ... Read More
-
ADME-Toxicology Testing
... at a CAGR of 10.9% over the analysis period 2023-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$9.6 Billion by the end ... Read More
-
qPCR and dPCR Instrumentation
... reach US$13.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. qPCR and dPCR Reagents & Consumables, one of the segments analyzed in the report, is expected to record a ... Read More
-
Antimicrobial Susceptibility Testing
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Manual Antimicrobial Susceptibility Testing Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach ... Read More
-
Stable Isotope Labeled Compounds
... reach US$432.5 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. Deuterium, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$183.4 ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
-
Molecular Cytogenetics
... at a CAGR of 8.8% over the analysis period 2023-2030. Molecular Cytogenetics Consumables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.0 Billion by the end ... Read More
-
Stromal Vascular Fraction
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Isolation Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$99.5 Million by ... Read More
-
Proteomics
... of 10.1% over the analysis period 2023-2030. Proteomics Reagents, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$49.2 Billion by the end of the analysis period. ... Read More
-
Bone Graft Substitutes
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Allograft, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.4 Billion by the ... Read More
-
Nucleic Acid Testing
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 ... Read More
-
Freeze Drying Equipment
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Tray-Style Freeze Dryers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$5.6 Billion ... Read More
-
Immunochemicals
... of 5.2% over the analysis period 2023-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Kidney Cancer Drugs
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.6 Billion by ... Read More
-
White Biotechnology
... at a CAGR of 7.9% over the analysis period 2023-2030. Bioenergy Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$203.1 Billion by the end of ... Read More
-
Nanocatalysts
... of 7.5% over the analysis period 2023-2030. Refinery & Petrochemicals Application, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Biochips
... of 12.8% over the analysis period 2023-2030. DNA Chip, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$14.7 Billion by the end of the analysis period. ... Read More
-
Biopreservation
... of 7.9% over the analysis period 2023-2030. Biopreservation Media, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$5.1 Billion by the end of the analysis period. ... Read More
-
US Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032 US Esoteric Testing Market is valued approximately USD 6.87 Billion in 2023 and is anticipated to grow with a ... Read More
-
Bone Growth Stimulators
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Stimulation Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$855.7 Million by ... Read More
-
In Situ Hybridization (ISH)
... reach US$1.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Cancer Diagnostics Application, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and ... Read More
-
Regenerative Medicine
... at a CAGR of 15.7% over the analysis period 2023-2030. Cell Therapy, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$16.9 Billion by the end of ... Read More
Research Assistance
